Touchstone International Medical Science Co., Ltd.
SSE:688013.SS
26.88 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 64.126 | 211.534 | 33.052 | 75.418 | 126.782 | 18.841 | 18.517 | 22.889 |
| Short Term Investments
| 330.998 | 218.521 | 329.285 | 355.493 | 252.558 | 0.195 | 3.455 | 0.453 |
| Cash and Short Term Investments
| 395.124 | 430.055 | 362.337 | 430.911 | 379.339 | 18.841 | 18.517 | 22.889 |
| Net Receivables
| 12.987 | 13.941 | 7.856 | 7.566 | 3.236 | 1.493 | 1.774 | 1.537 |
| Inventory
| 30.769 | 29.204 | 33.536 | 26.296 | 26.195 | 27.097 | 17.917 | 16.201 |
| Other Current Assets
| 6.78 | 1.625 | 3.729 | 1.259 | 1.517 | 1.822 | 4.123 | 1.145 |
| Total Current Assets
| 445.661 | 474.824 | 407.458 | 466.034 | 410.287 | 49.449 | 43.145 | 41.921 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 116.918 | 85.434 | 75.269 | 72.315 | 71.178 | 71.91 | 69.68 | 52.16 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 39.854 | 40.241 | 41.691 | 3.004 | 3.204 | 3.354 | 3.546 | 3.754 |
| Goodwill and Intangible Assets
| 39.854 | 40.241 | 41.691 | 3.004 | 3.204 | 3.354 | 3.546 | 3.754 |
| Long Term Investments
| -306.598 | -200.121 | -314.885 | 0.025 | 0.004 | 0.039 | 0.055 | 0.072 |
| Tax Assets
| 5.371 | 6.708 | 3.96 | 3.136 | 0.021 | 0.009 | 0.432 | 0.407 |
| Other Non-Current Assets
| 336.034 | 219.523 | 329.963 | 0.32 | 0.55 | 0.144 | 0.094 | 0.252 |
| Total Non-Current Assets
| 191.58 | 151.785 | 135.998 | 78.8 | 74.956 | 75.457 | 73.808 | 56.644 |
| Total Assets
| 637.24 | 626.609 | 543.456 | 544.834 | 485.243 | 124.906 | 116.953 | 98.565 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 9.923 | 12.884 | 7.765 | 8.687 | 3.066 | 6.535 | 7.915 | 8.17 |
| Short Term Debt
| 0 | 0.666 | 0.381 | 0 | 0 | 0 | 9 | 0 |
| Tax Payables
| 0.969 | 3.797 | 6.092 | 4.977 | 2.346 | 0.699 | 2.655 | 1.17 |
| Deferred Revenue
| 0 | 16.712 | 2.085 | 3.522 | 0.646 | 1.119 | 2.655 | 0.493 |
| Other Current Liabilities
| 40.421 | 16.89 | 16.149 | 17.117 | 11.759 | 9.408 | 10.411 | 7.675 |
| Total Current Liabilities
| 51.313 | 50.95 | 32.472 | 30.782 | 17.817 | 16.642 | 32.636 | 17.014 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 1.078 | 1.289 | 0.581 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0.428 | 0.3 | 0.4 | 0.7 | 1.45 | 1.08 | 1.415 | 1.71 |
| Deferred Tax Liabilities Non-Current
| 2.995 | 2.545 | 1.592 | 0.149 | 0.084 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 1.077 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 4.501 | 4.134 | 2.573 | 1.926 | 1.534 | 1.08 | 1.415 | 1.71 |
| Total Liabilities
| 55.814 | 55.084 | 35.045 | 32.707 | 19.35 | 17.721 | 34.051 | 18.725 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 81.156 | 81.156 | 81.156 | 80 | 80 | 60 | 43.668 | 43.668 |
| Retained Earnings
| 105.266 | 98.196 | 74.954 | 52.657 | 31.475 | 0.178 | 6.227 | 5.652 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 46.675 | 38.779 | 28.733 | 3.681 | 47.007 | 33.006 | 30.521 |
| Other Total Stockholders Equity
| 395.005 | 345.498 | 352.302 | 379.47 | 350.737 | 0 | 33.006 | 30.521 |
| Total Shareholders Equity
| 581.426 | 571.525 | 508.411 | 512.127 | 465.893 | 107.185 | 82.902 | 79.84 |
| Total Equity
| 581.426 | 571.525 | 508.411 | 512.127 | 465.893 | 107.185 | 82.902 | 79.84 |
| Total Liabilities & Shareholders Equity
| 637.24 | 626.609 | 543.456 | 544.834 | 485.243 | 124.906 | 116.953 | 98.565 |